Silexion Therapeutics Corp. (SLXN)
0.50
+0.02
(+5.26%)
USD |
NASDAQ |
May 22, 16:00
0.4673
-0.03
(-6.54%)
After-Hours: 20:00
Silexion Therapeutics Total Liabilities (Quarterly) : 4.311M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd. | 50.51M |
| Pluri, Inc. | 39.06M |
| BioLineRx Ltd. | 17.56M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 123.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.602M |
| Shareholders Equity (Quarterly) | 0.291M |
| Debt to Equity Ratio | 6.835 |
| Current Ratio | 1.001 |
| Net Debt Paydown Yield | 11.52% |